Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)

1.780 +0.190 (+11.95%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Price and Volume

Volume	2,256,946
Open	1.600
Bid (Size)	1.810 (100)
Ask (Size)	1.840 (13,200)
Prev. Close	1.590
Today's Range	1.598 - 1.808
52wk Range	1.070 - 6.175
Shares Outstanding	58,576,350
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 10, 2026

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-61.9%	-61.9%
1 Month	-64.0%	-64.0%
3 Month	-56.7%	-56.7%
6 Month	-67.0%	-67.0%
1 Year	-5.8%	-5.8%

More News

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 07, 2026

From Schall Law

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 03, 2026

From Schall Law

Via GlobeNewswire

ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

April 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Aldeyra Therapeutics, Inc. and Encourages Investors to Contact the Firm

April 01, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Aldeyra Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ALDX

April 01, 2026

From The DJS Law Group

Via Business Wire

INVESTOR ALERT: Securities Class Action Filed Against Aldeyra Therapeutics – Investors Encouraged to Contact Kirby McInerney LLP

March 31, 2026

From Kirby McInerney LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 31, 2026

From The Schall Law Firm

Via Business Wire

ALDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

March 31, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Aldeyra Therapeutics, Inc. Class Action

March 31, 2026

From Robbins LLP

Via Business Wire

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Aldeyra Therapeutics, Inc. Investors – ALDX

March 30, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

ALDX Investor News: If You Have Suffered Losses in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

March 28, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

March 24, 2026

Via Chartmill

These stocks have an unusual volume in today's session ↗

March 23, 2026

Via Chartmill

Rosen Law Firm Encourages Aldeyra Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – ALDX

March 20, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Top movers in Thursday's session ↗

March 19, 2026

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

March 19, 2026

Via Chartmill

Top stock movements in today's session. ↗

March 17, 2026

Via Chartmill

Gapping stocks in Tuesday's session ↗

March 17, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Tuesday. ↗

March 17, 2026

Via Chartmill

Why Did ALDX Stock Tank 75% In Pre-Market Today? ↗

March 17, 2026

Via Stocktwits

Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease

March 17, 2026

From Aldeyra Therapeutics, Inc.

Via Business Wire

Frequently Asked Questions

Is Aldeyra Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aldeyra Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aldeyra Therapeutics, Inc. - Common Stock trade on?

Aldeyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock?

The ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock is ALDX on the Nasdaq Stock Market

What is the current price of Aldeyra Therapeutics, Inc. - Common Stock?

The current price of Aldeyra Therapeutics, Inc. - Common Stock is 1.780

When was Aldeyra Therapeutics, Inc. - Common Stock last traded?

The last trade of Aldeyra Therapeutics, Inc. - Common Stock was at 04/10/26 04:00 PM ET

What is the market capitalization of Aldeyra Therapeutics, Inc. - Common Stock?

The market capitalization of Aldeyra Therapeutics, Inc. - Common Stock is 104.27M

How many shares of Aldeyra Therapeutics, Inc. - Common Stock are outstanding?

Aldeyra Therapeutics, Inc. - Common Stock has 104M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.